Valuation: Biogen Inc.

Market Cap 3.36TCr 2.96TCr 2.8TCr 2.54TCr 4.76TCr 3,22000Cr 4.8TCr 33TCr 13TCr 1,64400Cr 13TCr 12TCr 5,27700Cr P/E 2026 *
37x
P/E 2027 * 20.1x
Enterprise Value 3.85TCr 3.39TCr 3.21TCr 2.91TCr 5.46TCr 3,69400Cr 5.51TCr 38TCr 15TCr 1,88600Cr 14TCr 14TCr 6,05300Cr EV / Sales 2026 *
3.69x
EV / Sales 2027 * 3.38x
Free-Float
85.8%
Yield 2026 *
-
Yield 2027 * -
1 day-1.37%
1 week+3.57%
Current month+5.78%
1 month+5.89%
3 months+20.10%
6 months+22.56%
Current year+32.70%
1 week 195.88
Extreme 195.88
201.75
1 month 181.12
Extreme 181.12
201.75
Current year 134.7
Extreme 134.7
201.75
1 year 117.05
Extreme 117.05
201.75
3 years 99
Extreme 99
255.4
5 years 99
Extreme 99
317.45
10 years 99
Extreme 99
351.7
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 28/10/2024
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Change 5-day change 1-year change 3-year change Capi.($)
-1.37%+3.57% - - 3.38TCr
+3.13%+17.65%+730.79%+102.91% 7.88TCr
-0.23%-5.97%+33.09%-10.07% 7.51TCr
+0.21%+2.24%-6.14%-27.67% 6.11TCr
-2.68%-2.50%+5.03%+165.47% 4.61TCr
-1.07%-1.21%-9.92%+32.27% 4.76TCr
-0.71%+3.65%+65.30%-11.93% 3.38TCr
-1.30%-1.16%+48.97%+110.20% 2.53TCr
-0.26%-6.35%+2.84%+140.35% 2.13TCr
-0.64%-1.58%+60.16%+95.78% 1.54TCr
Average -0.49%-0.64%+103.35%+66.37% 4.49TCr
Weighted average by Cap. -0.12%+0.45%+157.89%+53.57%

Financials

2026 *2027 *
Net sales 1.04TCr 920.87Cr 870.96Cr 789.56Cr 1.48TCr 1,00200Cr 1.49TCr 10TCr 4.02TCr 51TCr 3.92TCr 3.84TCr 1,64300Cr 1.07TCr 939.74Cr 888.8Cr 805.74Cr 1.51TCr 1,02300Cr 1.53TCr 11TCr 4.1TCr 52TCr 4TCr 3.91TCr 1,67600Cr
Net income 100Cr 88Cr 83Cr 75Cr 141.44Cr 9.57TCr 142.67Cr 994.21Cr 383.49Cr 4.88TCr 374.27Cr 366.1Cr 16TCr 185.88Cr 163.9Cr 155.01Cr 140.53Cr 263.75Cr 18TCr 266.05Cr 1.85TCr 715.12Cr 9.11TCr 697.94Cr 682.7Cr 29TCr
Net Debt 493.67Cr 435.29Cr 411.7Cr 373.22Cr 700.49Cr 47TCr 706.6Cr 4.92TCr 1.9TCr 24TCr 1.85TCr 1.81TCr 78TCr 242Cr 213.38Cr 201.82Cr 182.96Cr 343.38Cr 23TCr 346.38Cr 2.41TCr 931.03Cr 12TCr 908.66Cr 888.82Cr 38TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
29/26/29 €198.98 -1.37% 3
28/26/28 €201.75 +2.29% 6
25/26/25 €197.24 -0.38% 109
24/26/24 €198.00 +0.68% 186
23/26/23 €196.66 -0.50% 41
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
35
Last Close Price
228.69USD
Average target price
238.18USD
Spread / Average Target
+4.15%

Quarterly revenue - Rate of surprise